Kiniksa Pharmaceuticals International (KNSA) Change in Inventory (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Change in Inventory came in at -$2.2 million in Q2 2026, down 108.47% YoY from $26.1 million in Q2 2025, and down 112.12% on a QoQ basis from $18.2 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Change in Inventory (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Change in Inventory data on file, last reported at -$2.2 million in Q2 2026.
- Quarterly Change in Inventory fell 108.47% year-over-year to -$2.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $22.7 million (up 70.75% YoY) and the FY2025 annual result came in at $28.5 million, up 699.64% from the prior year.
- Change in Inventory fell to -$2.2 million in Q2 2026, from $18.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $26.1 million in Q2 2025 to a low of -$6.8 million in Q3 2025.
- A 5-year average of $3.7 million and a median of $1.7 million in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory tumbled 583.23% — and 2024, when it surged 1322.14%.
- Tracing KNSA's Change in Inventory over 5 years: stood at $7.0 million in 2022, then decreased by 20.62% to $5.5 million in 2023, then sank by 141.81% to -$2.3 million in 2024, then jumped by 682.86% to $13.5 million in 2025, then tumbled by 116.38% to -$2.2 million in 2026.
- The last three Change in Inventory figures came in at -$2.2 million (Q2 2026), $18.2 million (Q1 2026), and $13.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.08 Bn | 5.56 Bn | 220.03 Mn | -2.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.21 Mn |
| Jun 30, 2026 | -2.21 Mn |
| Mar 31, 2026 | 18.25 Mn |
| Mar 31, 2026 | 18.25 Mn |
| Dec 31, 2025 | 13.50 Mn |
| Dec 31, 2025 | 13.50 Mn |
| Sep 30, 2025 | -6.79 Mn |
| Sep 30, 2025 | -6.79 Mn |
| Jun 30, 2025 | 26.11 Mn |
| Jun 30, 2025 | 26.11 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Jun 30, 2024 | 7.58 Mn |
| Jun 30, 2024 | 7.58 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Mar 31, 2024 | -3.84 Mn |